CIK 0001314102
- Non-accelerated filer
- Smaller reporting company
EyePoint, Inc.
Sign in to watch- Ticker
- EYPT
- Exchange
- Nasdaq
- Industry
- Laboratory Analytical Instruments
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 262774444
- Phone
- +1 617-926-5000
- Business address
- 480 PLEASANT STREET, SUITE C400, WATERTOWN, MA, 02472
- Former names
- EyePoint Pharmaceuticals, Inc., pSivida Corp., pSivida LTD
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-01-02 | ANDO GORAN Director | Grant or award · Stock Option (Right to Buy) | +41,500 | 41,500 | ||
| 2025-01-03 | ANDO GORAN Director | Grant or award · Stock Option (Right to Buy) | +41,500 | 41,500 | ||
| 2024-08-21 | ANDO GORAN Director | Purchase | +5,000 | $7.95 | $40K | 13,150 |
| 2024-01-05 | ANDO GORAN Director | Grant or award · Stock Option (Right to Buy) | +23,598 | 23,598 | ||
| 2023-06-20 | ANDO GORAN Director | Grant or award · Stock Option (Right to Buy) | +27,100 | 27,100 | ||
| 2023-06-20 | ANDO GORAN Director | Grant or award · Stock Option (Right to Buy) | +13,500 | 13,500 | ||
| 2023-02-09 | ANDO GORAN Director | Exercise or conversion | +3,250 | 8,150 | ||
| 2023-02-09 | ANDO GORAN Director | Exercise or conversion · Restricted Stock Units | −3,250 | 0 | ||
| 2022-02-09 | ANDO GORAN Director | Exercise or conversion | +2,750 | 4,900 | ||
| 2022-02-09 | ANDO GORAN Director | Grant or award · Restricted Stock Units | +3,250 | 3,250 | ||
| 2022-02-09 | ANDO GORAN Director | Exercise or conversion · Restricted Stock Units | −2,750 | 0 | ||
| 2022-02-09 | ANDO GORAN Director | Grant or award · Stock Option (Right to Buy) | +12,000 | 12,000 | ||
| 2021-06-22 | ANDO GORAN Director | Grant or award · Restricted Stock Units | +2,750 | 2,750 | ||
| 2021-06-22 | ANDO GORAN Director | Grant or award · Stock Option (Right to Buy) | +12,000 | 12,000 | ||
| 2021-02-28 | ANDO GORAN Director | Exercise or conversion | +2,150 | 2,150 | ||
| 2021-02-28 | ANDO GORAN Director | Exercise or conversion · Restricted Stock Units | −2,150 | 0 | ||
| 2020-02-28 | ANDO GORAN Director | Grant or award · Restricted Stock Units | +21,500 | 21,500 | ||
| 2020-02-28 | ANDO GORAN Director | Grant or award · Stock Option (Right to Buy) | +38,500 | 38,500 | ||
| 2019-06-25 | ANDO GORAN Director | Grant or award · Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2018-10-11 | ANDO GORAN Director | Grant or award · Employee Stock Option (right to buy) | +15,000 | 15,000 |
Page 1 of 2 · 21 trades